ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells
Authors
Keywords
-
Journal
CELL DEATH AND DIFFERENTIATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-13
DOI
10.1038/s41418-019-0362-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetic Silencing of TAP1 in Aldefluor+ Breast Cancer Stem Cells Contributes to Their Enhanced Immune Evasion
- (2018) Mohammad Sultan et al. STEM CELLS
- DNA Methylation Predicts the Response of Triple-Negative Breast Cancers to All-Trans Retinoic Acid
- (2018) Krysta Coyle et al. Cancers
- Differential Functional Roles of ALDH1A1 and ALDH1A3 in Mediating Metastatic Behavior and Therapy Resistance of Human Breast Cancer Cells
- (2017) Alysha Croker et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases
- (2017) Kathleen M. Schoch et al. NEURON
- ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment
- (2017) M Pérez-Alea et al. ONCOGENE
- Discovery of Cancer Driver Long Noncoding RNAs across 1112 Tumour Genomes: New Candidates and Distinguishing Features
- (2017) Andrés Lanzós et al. Scientific Reports
- Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells
- (2017) Richard Heery et al. Cancers
- Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells
- (2017) Jia Deng et al. PLoS One
- Profiling of the transcriptional response to all-trans retinoic acid in breast cancer cells reveals RARE-independent mechanisms of gene expression
- (2017) Krysta Mila Coyle et al. Scientific Reports
- Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma
- (2016) Marjorie Flahaut et al. BMC CANCER
- miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
- (2016) András Lánczky et al. BREAST CANCER RESEARCH AND TREATMENT
- FOXD1–ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells
- (2016) Peng Cheng et al. CANCER RESEARCH
- Hide-and-seek: the interplay between cancer stem cells and the immune system
- (2016) Mohammad Sultan et al. CARCINOGENESIS
- ALDH1A3, the Major Aldehyde Dehydrogenase Isoform in Human Cholangiocarcinoma Cells, Affects Prognosis and Gemcitabine Resistance in Cholangiocarcinoma Patients
- (2016) Ming-Huang Chen et al. CLINICAL CANCER RESEARCH
- ALDH1A3, a metabolic target for cancer diagnosis and therapy
- (2016) Jiang-Jie Duan et al. INTERNATIONAL JOURNAL OF CANCER
- Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3
- (2016) Margaret Lois Thomas et al. Molecular Oncology
- Melanoma addiction to the long non-coding RNA SAMMSON
- (2016) Eleonora Leucci et al. NATURE
- Long noncoding RNA LINP1 regulates repair of DNA double-strand breaks in triple-negative breast cancer
- (2016) Youyou Zhang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment
- (2016) Keisuke Katsushima et al. Nature Communications
- Long noncoding RNA LINP1 regulates repair of DNA double-strand breaks in triple-negative breast cancer
- (2016) Youyou Zhang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Breast cancer subtype dictates DNA methylation and ALDH1A3-mediated expression of tumor suppressor RARRES1
- (2016) Krysta M. Coyle et al. Oncotarget
- Long Non-coding RNAs in the Cytoplasm
- (2016) Farooq Rashid et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2
- (2016) Mengying Wu et al. Scientific Reports
- Downregulated lincRNA HOTAIR expression in ovarian cancer stem cells decreases its tumorgeniesis and metastasis by inhibiting epithelial-mesenchymal transition
- (2015) Jing Wang et al. Cancer Cell International
- TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer
- (2015) Jun Li et al. CANCER RESEARCH
- Long Noncoding RNA MALAT-1 Enhances Stem Cell-Like Phenotypes in Pancreatic Cancer Cells
- (2015) Feng Jiao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Long noncoding RNA linc00617 exhibits oncogenic activity in breast cancer
- (2015) Hengyu Li et al. MOLECULAR CARCINOGENESIS
- Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides
- (2015) Kim A. Lennox et al. NUCLEIC ACIDS RESEARCH
- ALDH1A3: A Marker of Mesenchymal Phenotype in Gliomas Associated with Cell Invasion
- (2015) Wenlong Zhang et al. PLoS One
- LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway
- (2015) Mingli Zhou et al. STEM CELLS
- Mammosphere Formation Assay from Human Breast Cancer Tissues and Cell Lines
- (2015) Ylenia Lombardo et al. Jove-Journal of Visualized Experiments
- Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells
- (2015) Maroof Alam et al. Oncotarget
- Essential Role of Aldehyde Dehydrogenase 1A3 for the Maintenance of Non-Small Cell Lung Cancer Stem Cells Is Associated with the STAT3 Pathway
- (2014) C. Shao et al. CLINICAL CANCER RESEARCH
- Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling
- (2014) Paola Marcato et al. Molecular Oncology
- LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis
- (2014) P Hou et al. Cell Death & Disease
- A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
- (2013) X. Zhang et al. CANCER RESEARCH
- Positive ALDH1A3 and Negative GPX3 Expressions Are Biomarkers for Poor Prognosis of Gallbladder Cancer
- (2013) Zhu-lin Yang et al. DISEASE MARKERS
- Long Noncoding RNAs: Past, Present, and Future
- (2013) J. T. Y. Kung et al. GENETICS
- Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3
- (2013) P. Mao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer
- (2012) Julia Y. S. Tsang et al. BREAST CANCER RESEARCH AND TREATMENT
- Genome-wide DNA methylation profiling identifies ALDH1A3 promoter methylation as a prognostic predictor in G-CIMP− primary glioblastoma
- (2012) Wei Zhang et al. CANCER LETTERS
- The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells
- (2012) T. Gutschner et al. CANCER RESEARCH
- A Detailed Mammosphere Assay Protocol for the Quantification of Breast Stem Cell Activity
- (2012) Frances L. Shaw et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- In Situ Identification of CD44+/CD24− Cancer Cells in Primary Human Breast Carcinomas
- (2012) Giuseppe Perrone et al. PLoS One
- ALDH1A Isozymes are Markers of Human Melanoma Stem Cells and Potential Therapeutic Targets
- (2012) Yuchun Luo et al. STEM CELLS
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Chromatin Isolation by RNA Purification (ChIRP)
- (2012) Ci Chu et al. Jove-Journal of Visualized Experiments
- Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform
- (2011) Paola Marcato et al. CELL CYCLE
- CD44+/CD24−/low cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome
- (2011) Michael O. Idowu et al. HUMAN PATHOLOGY
- The CD44+/CD24− phenotype relates to ‘triple-negative’ state and unfavorable prognosis in breast cancer patients
- (2010) Alexandra Giatromanolaki et al. MEDICAL ONCOLOGY
- Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of Metastasis
- (2010) Paola Marcato et al. STEM CELLS
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- If cancer stem cells are resistant to current therapies, what’s next?
- (2009) Paola Marcato et al. Future Oncology
- MEME SUITE: tools for motif discovery and searching
- (2009) T. L. Bailey et al. NUCLEIC ACIDS RESEARCH
- Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis
- (2008) Christine E. Eyler et al. JOURNAL OF CLINICAL ONCOLOGY
- Model-based Analysis of ChIP-Seq (MACS)
- (2008) Yong Zhang et al. GENOME BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started